Reference no: EM133841418

Question

GDM is primarily initially identified by screening tests in pregnancy. Because early screening is indicated by clinical history and assessment, documenting past medical history, obstetric outcomes, and family history of type 2 diabetes mellitus are essential components of GDM assessment. The clinical features of gestational diabetes mellitus can be varied. The disproportionate weight gain, obesity, and elevated BMI can be suggestive features.[1] The American College of Obstetricians and Gynecologists (ACOG) recommends targeted evaluation for type 2 diabetes early in pregnancy with a 75-g or 50-g oral glucose tolerance test at the initial prenatal visit in patients who have a BMI of 30 kg/m2 or more and 1 of the following risk factors: History of gestational diabetes mellitus Hemoglobin A1C ≥5.7% on previous testing Immediate family member with diabetes High-risk race (eg, African American, Latin American, Native American, Asian American, Pacific Islander) Cardiovascular disease history Hypertension High-density lipoprotein (HDL) cholesterol level <35 mg/dL or a triglyceride level >250 mg/dL Polycystic ovary syndrome Physical inactivity [6][1] However, studies have demonstrated that the most significant associations for GDM risk were family history, previous GDM, Southeast Asian ethnicity, parity, and high BMI. Therefore, ethnic and racial differences in these risk factors for GDM development should also be considered.[7] Additionally, recent st.